Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

OREF/UConn Collaboration to Support The Cato T. Laurencin Institute for Regenerative Engineering


News provided by

Orthopaedic Research and Education Foundation

Nov 01, 2023, 08:00 ET

Share this article

Share toX

Share this article

Share toX

OREF and UConn Foundation announce new partnership.
OREF and UConn Foundation announce new partnership.

The organizations will work together to promote and raise funds for The Cato T. Laurencin Institute for Regenerative Engineering.

ROSEMONT, Ill., Nov. 1, 2023 /PRNewswire-PRWeb/ -- The Orthopaedic Research and Education Foundation (OREF) and the UConn Foundation today announced a new partnership to support The Cato T. Laurencin Institute for Regenerative Engineering at the University of Connecticut. Regenerative engineering is a field pioneered by Cato T. Laurencin, MD, PhD, the University Professor and Albert and Wilda Van Dusen Chair in Academic Medicine Distinguished Endowed Professor of Orthopaedic Surgery at UConn. Dr. Laurencin is the first surgeon elected to the four national academies: the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. In orthopaedic surgery, Dr. Laurencin is the first to receive the American Orthopaedic Association's Distinguished Contributions to Orthopaedics Award, the Nicholas Andry Lifetime Achievement Award from the Association of Bone and Joint Surgeons, the Kappa Delta Award from the American Academy of Orthopaedic Surgeons, and the Marshall R. Urist Award from the Orthopaedic Research Society. Funds raised through this partnership will support the core programs of The Cato T. Laurencin Institute.

Regenerative engineering, as defined by Dr. Laurencin, is the convergence of advanced materials science, stem cell science, physics, developmental biology, and clinical translation, for the regeneration of complex tissues and organ systems. The groundbreaking work of Dr. Laurencin includes the launch of the Hartford Engineering a Limb (HEAL) Project aimed at regenerating whole limbs. Musculoskeletal technologies developed by Dr. Laurencin earned him the National Medal of Technology and Innovation, America's highest honor for technological achievement, given in ceremonies at the White House. Dr. Laurencin is the 2023 Inventor of the Year, named by the Intellectual Property Owner's Education Foundation.

"This new partnership is exciting [and] will advance clinical treatment and patient outcomes through novel research, and through translating findings directly to technologies helping people." Cato T. Laurencin, MD, PhD

Post this

As part of the collaboration, the OREF will work to grow awareness of and support for The Cato T. Laurencin Institute as well as provide a mechanism for donors to give through the OREF website. "OREF is committed to improving care and outcomes for all patients, including those impacted by musculoskeletal injuries, illness or congenital issues affecting the limbs," noted OREF President Thomas P. Sculco, MD. "We are delighted to partner with Dr. Laurencin and The Cato T. Laurencin Institute for Regenerative Engineering to support his important and breakthrough work."

Dr. Laurencin, the Chief Executive Officer of The Cato T. Laurencin Institute for Regenerative Engineering, stated, "the Orthopaedic Research and Education Foundation and The Cato T. Laurencin Institute share a vision of producing leading edge research that ultimately translates to leading edge care of our patients. The Cato T. Laurencin Institute for Regenerative Engineering represents a transdisciplinary effort integrating medicine, engineering, surgery, biology, physics, chemistry, and statistics/machine learning to enable a powerful platform for addressing scientific and medical problems in the regeneration and healing of complex tissues, organs, or organ systems. This new partnership is exciting. It will advance clinical treatment and patient outcomes through novel research, and through translating findings directly to technologies helping people."

To make a gift, visit the OREF website at https://www.oref.org/Laurencin. Funds raised through this partnership will support the core programs of The Cato T. Laurencin Institute and OREF's research mission. Ninety-five percent of each gift will be directed by OREF to the UConn Foundation, Inc to support The Cato T. Laurencin Institute programs and five percent will support OREF's research programs. Additional information about the UConn Foundation is available at https://www.foundation.uconn.edu/financial-information/

To learn more about The Cato T. Laurencin Institute for Regenerative Engineering, visit OREF's website or the institute's website at https://health.uconn.edu/regenerative-engineering-institute/.

About the Orthopaedic Research and Education Foundation
An independent 501(c)3 nonprofit, OREF strives to improve clinical care and patient outcomes by advancing innovative research, developing new investigators, and uniting the orthopaedic community in promoting musculoskeletal health. The Foundation raises funds to support research on diseases and injuries of bones, nerves, muscles, and tendons and to enhance clinical care leading to improved health, increased activity, and a better quality of life for patients. For more information, visit https://www.oref.org and follow us on Twitter and LinkedIn.

About the Cato T. Laurencin Institute for Regenerative Engineering at UConn
Founded by Cato T. Laurencin, MD, PhD, The Cato T. Laurencin Institute for Regenerative Engineering is a cross-university Institute focused on breakthrough technologies for complex tissue regeneration. For more information, visit https://health.uconn.edu/regenerative-engineering-institute/.

About the UConn Foundation
The UConn Foundation, Inc. is an independent, not-for-profit, tax-exempt organization that operates exclusively to promote the educational, scientific, cultural, research, and recreational objectives of the University of Connecticut. The Foundation does this by providing quality programs and services for its alumni and supporters, and by serving as the primary fundraising vehicle for the University. The Foundation solicits, administers, and invests private funds for the sole benefit of the University and its mission of pursuing excellence in teaching, research, and public service. For more information, visit http://www.foundation.uconn.edu or find us on Twitter, Facebook, YouTube, and LinkedIn. 

Media Contact

Karen Pubentz, Orthopaedic Research and Education Foundation, 8474305113, [email protected], www.oref.org 

Twitter

SOURCE Orthopaedic Research and Education Foundation

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.